ea0070aep200 | Bone and Calcium | ECE2020
Tripto-Shkolnik Liana
, Yekutiel Naama
, Chodick Gabriel
, Shalev Varda
, Goldshtein Inbal
Introduction: Denosumab discontinuation rapidly reverses bone turnover inhibition and eliminates anti-fracture protection. Multiple vertebral fractures (MVF) were reported in this scenario. Previously, we reported a retrospective real-life analysis designed to estimate fracture risk following denosumab discontinuation. Here we report a patient-level data of a subgroup with MVF.Methods: Via computerized database of Maccabi Healthcare Services, persistent ...